Results 311 to 320 of about 19,967,816 (378)

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

open access: yesMolecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen   +9 more
wiley   +1 more source

Magnetic field based investigation of Brugada syndrome. [PDF]

open access: yesEur Biophys J
Nicoletti M   +6 more
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Fine-Tuning Positive-Surface-Charge Carbon Dots for High-Efficiency and Low-Cytotoxicity Gene Delivery. [PDF]

open access: yesNanomaterials (Basel)
Zhang S   +7 more
europepmc   +1 more source

In vivo efficacy of current stimuli computed by optimal tracking of neuron membrane voltage. [PDF]

open access: yesPLoS One
Ferguson AC   +5 more
europepmc   +1 more source

Ligand Design Criteria for the Stability of High Oxidation State Praseodymium Complexes. [PDF]

open access: yesInorg Chem
Nero TR   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy